Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Daily Values
Growth Metrics
Income Statement
Others
Ratios

China Pharma Holdings (CPHI) Gains from Investment Securities: 2009-2023

Historic Gains from Investment Securities for China Pharma Holdings (CPHI) over the last 5 years, with Dec 2023 value amounting to $201,865.

  • China Pharma Holdings' Gains from Investment Securities was N/A to $201,865 in Q4 2023 from the same period last year, while for Dec 2023 it was -$2,124, marking a year-over-year change of. This contributed to the annual value of $156,273 for FY2023, which is N/A change from last year.
  • As of Q4 2023, China Pharma Holdings' Gains from Investment Securities stood at $201,865, which was up 198.70% from -$204,518 recorded in Q3 2023.
  • In the past 5 years, China Pharma Holdings' Gains from Investment Securities registered a high of $236,055 during Q1 2019, and its lowest value of -$204,518 during Q3 2023.
  • Over the past 2 years, China Pharma Holdings' median Gains from Investment Securities value was $264.50 (recorded in 2021), while the average stood at -$531.